Victory Capital Management Inc Acer Therapeutics Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.53 - $4.53 $1,364 - $4,040	-892 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.18 - $5.86 $23 - $117	-20 Reduced 2.19%	892 $2,000
Q4 2019 Feb 04, 2020	BUY	$2.85 - $4.2 $356 - $525	125 Added 15.88%	912 $3,000
Q3 2019 Nov 12, 2019	BUY	$1.95 - $3.93 $1,534 - $3,092	787 New	787 $3,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.